Data as of Oct 22
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Tenax Therapeutics Inc have a median target of 10.50, with a high estimate of 10.50 and a low estimate of 10.50. The median estimate represents a +183.78% increase from the last price of 3.70.
The current consensus among 1 polled investment analysts is to Buy stock in Tenax Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.